Russell E. Ware

24.5k total citations · 3 hit papers
410 papers, 15.7k citations indexed

About

Russell E. Ware is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Russell E. Ware has authored 410 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 330 papers in Genetics, 285 papers in Hematology and 85 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Russell E. Ware's work include Hemoglobinopathies and Related Disorders (324 papers), Iron Metabolism and Disorders (208 papers) and Blood groups and transfusion (101 papers). Russell E. Ware is often cited by papers focused on Hemoglobinopathies and Related Disorders (324 papers), Iron Metabolism and Disorders (208 papers) and Blood groups and transfusion (101 papers). Russell E. Ware collaborates with scholars based in United States, Uganda and Canada. Russell E. Ware's co-authors include Sherri A. Zimmerman, William H. Schultz, Patrick T. McGann, Thad A. Howard, Winfred C. Wang, Banu Aygün, Ronald W. Helms, Miguel R. Abboud, Thomas R. Kinney and Nicole A. Mortier and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Russell E. Ware

394 papers receiving 15.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of Sickle Cell Disease

2014 1.0k citations Russell E. Ware, Jonathan C. Goldsmith et al. profile →
Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease

2000 800 citations Russell E. Ware et al. profile →
Sickle cell disease

2017 619 citations Russell E. Ware, Mariane de Montalembert et al. profile →

Peers

Countries citing papers authored by Russell E. Ware

Since Specialization

Citations

This map shows the geographic impact of Russell E. Ware's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell E. Ware with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell E. Ware more than expected).

Fields of papers citing papers by Russell E. Ware

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell E. Ware. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell E. Ware. The network helps show where Russell E. Ware may publish in the future.

Co-authorship network of co-authors of Russell E. Ware

This figure shows the co-authorship network connecting the top 25 collaborators of Russell E. Ware. A scholar is included among the top collaborators of Russell E. Ware based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell E. Ware. Russell E. Ware is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hydroxyurea to decrease stroke risk in children with sickle cell anemia: a systematic review and meta-analysis 2025 ·PubMed ·Emmanuela E. Ambrose, (unknown), (unknown), Russell E. Ware, Abel Makubi, Luke R. Smart	0
2	Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations 2025 ·Blood Advances ·Alexandra Power‐Hays, Kathryn McElhinney, Thomas N. Williams, George Mochamah, Peter Olupot‐Olupot, (unknown), Marvin Reid, Angela Rankine‐Mullings, Robert O. Opoka, Chandy C. John, Patrick T. McGann, Charles T. Quinn, Nieko Punt, Luke R. Smart, Susan E. Stuber, Teresa Latham, Alexander A. Vinks, Russell E. Ware	0
3	Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial 2025 ·Blood Advances ·Rosa M. Nieves, Teresa Latham, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Daniel Ramírez, (unknown), (unknown), (unknown), (unknown), Susan E. Stuber, William H. Schultz, Adam Lane, (unknown), Russell E. Ware	3
4	Reducing transfusion utilization for children with sickle cell anemia in sub‐Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial 2024 ·American Journal of Hematology ·Alexandra Power‐Hays, George Tomlinson, Léon Tshilolo, Brígida Santos, Thomas N. Williams, Peter Olupot‐Olupot, Luke R. Smart, Banu Aygün, Adam Lane, Susan E. Stuber, Teresa Latham, Russell E. Ware	6
5	Successes and pitfalls in orphan drug development for sickle cell disease 2024 ·Blood Advances ·Enrico Costa, Antonella Isgrò, Mariane de Montalembert, Hubert G. M. Leufkens, Russell E. Ware, Lucia De Franceschi	7
6	Baseline characteristics of Ghanaian children and adults enrolled in PIVOT , a randomised clinical trial of hydroxyurea in HbSC disease in sub‐Saharan Africa 2024 ·British Journal of Haematology ·(unknown), Luke R. Smart, Susan E. Stuber, Kwesi Nyan Amissah-Arthur, (unknown), (unknown), (unknown), Adam Lane, (unknown), (unknown), (unknown), Emmanuella Amoako, Teresa Latham, Yvonne Dei‐Adomakoh, Russell E. Ware	0
7	Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC disease 2023 ·Trials ·Luke R. Smart, Catherine Segbefia, Teresa Latham, Susan E. Stuber, Kwesi Nyan Amissah-Arthur, (unknown), Adam Lane, Yvonne Dei‐Adomakoh, Russell E. Ware	2
8	Genome‐wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci 2023 ·British Journal of Haematology ·Eric J. Earley, Shannon Kelly, Fang Fang, Cecília Salete Alencar, Daniela de Oliveira Werneck Rodrigues, (unknown), Jonathan M. Flanagan, Russell E. Ware, Xu Zhang, Victor R. Gordeuk, Mark T. Gladwin, Yingze Zhang, Mehdi Nouraie, Sergeï Nekhai, Éster Cerdeira Sabino, Brian Custer, Carla Luana Dinardo, Grier P. Page	3
9	Simultaneous adjunctive treatment of malaria and its coevolved genetic disorder sickle cell anemia 2023 ·Blood Advances ·Innocent Safeukui, Russell E. Ware, Narla Mohandas, Kasturi Haldar	3
10	Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia 2023 ·Blood Advances ·Angela Rankine‐Mullings, Russell Keenan, Subarna Chakravorty, Baba Inusa, Paul Telfer, Mark Velangi, Russell E. Ware, (unknown), (unknown), Sarah Edwards, Hussain Mulla	5
11	Pharmacokinetics of L-Glutamine (Endari) in Pediatric and Adult Sickle Cell Disease Patients: A Phase 4, Open-Label, Single-Center Study 2021 ·Blood ·Alina Sadaf, Min Dong, (unknown), Teresa Latham, Alexander A. Vinks, Russell E. Ware, Charles T. Quinn	1
12	Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia 2017 ·Blood ·Robert O. Opoka, Christopher M. Ndugwa, Teresa Latham, Adam Lane, Heather Hume, Phillip Kasirye, James S. Hodges, Russell E. Ware, Chandy C. John	98
13	Hemoglobin variants identified in the Uganda Sickle Surveillance Study 2016 ·Blood Advances ·Beverly A. Schaefer, Charles Kiyaga, Thad A. Howard, Grace Ndeezi, Arielle G. Hernandez, Isaac Ssewanyana, Mary Paniagua, Christopher M Ndugwa, Jane Ruth Aceng, Russell E. Ware	8
14	Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial 2016 ·JMIR Research Protocols ·(unknown), (unknown), (unknown), Phillip Kasirye, Heather Hume, Robert O. Opoka, Teresa Latham, Christopher M. Ndugwa, Russell E. Ware, Chandy C. John	18
15	Optimizing hydroxyurea therapy for sickle cell anemia 2015 ·Hematology ·Russell E. Ware	40
16	Immunologic Effects of Hydroxyurea in Sickle Cell Anemia 2014 ·PEDIATRICS ·Howard M. Lederman, Margaret A. Connolly, Ram Kalpatthi, Russell E. Ware, Winfred C. Wang, Lori Luchtman‐Jones, Myron A. Waclawiw, Jonathan C. Goldsmith, (unknown), James F. Casella	38
17	Impact of hydroxyurea on clinical events in the BABY HUG trial 2012 ·Blood ·Courtney D. Thornburg, Beatrice Files, Zhaoyu Luo, Scott T. Miller, Ram Kalpatthi, Rathi V. Iyer, Phillip Seaman, Jeffrey D. Lebensburger, Ofelia Álvarez, Bruce Thompson, Russell E. Ware, Winfred C. Wang	184
18	Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia 2007 ·Blood ·Sherri A. Zimmerman, William H. Schultz, (unknown), Nicole A. Mortier, Russell E. Ware	149
19	Immunologic effects of anti-D (WinRho-SD) in children with immune thrombocytopenic purpura 1998 ·American Journal of Hematology ·Sherri A. Zimmerman, Frank Malinoski, Russell E. Ware	17
20	Immunologic effects of anti‐D (WinRho‐SD) in children with immune thrombocytopenic purpura 1998 ·American Journal of Hematology ·Sherri A. Zimmerman, Frank Malinoski, Russell E. Ware	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact